- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Goldman, one of the largest shareholders in a Bermuda-based mortgage insurer, sold part of its stake as the company filed to sell shares to the public.
CME hosted a three-day shindig in Florida with the likes of Ben Bernanke, Colin Powell, Jay Leno and Michael Milken. Here's what it was like.
Investors are increasingly behaving like pros, according to TD Ameritrade Strategist JJ Kinahan.
The question isn’t easy to answer, says first amendment scholar and University of Chicago Professor Geoffrey Stone.
MIT professor Andrew Lo says regulations need to be updated.
MIT professor Andrew Lo would ideally like to see more diversification.
Saudi Aramco-style attack in the U.S. is one of his greatest fears.
Hedge fund Argentiere Capital focuses on volatility.
Bernanke and Mervyn King thought the global economy would recover more quickly and are reportedly pessimistic about a European revival.
Publisher Steve Forbes sees the potential for a bill to cut corporate taxes to pass next year.